Glioma invasion in vitro: Regulation by matrix metalloprotease-2 and protein kinase C

Clinical and Experimental Metastasis

Volumn 14, Issue 5, 1996, Pages 421-433

  Uhm, Joon H ^a   Dooley, Nora P ^a   Villemure, Jean Guy ^a   Yong, Voon Wee ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Glioma; Invasion; Metalloprotease; Protein kinase C; Zymography

Indexed keywords

1,10 PHENANTHROLINE; CALPHOSTIN C; ENZYME INHIBITOR; GELATINASE; PHORBOL ESTER; PROTEIN KINASE C; SYNTHETIC PEPTIDE;

ARTICLE; CANCER INVASION; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY;

CELL DIVISION; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; GELATINASES; GLIOMA; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NAPHTHALENES; NEOPLASM INVASIVENESS; PROTEIN KINASE C; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0029906468     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00128958     Document Type: Article

References (63)

1. Berens ME, Rutka JT and Rosenblum ML, 1990, Brain tumor epidemiology, growth, and invasion. Neurosurg Clinics N Am, 1, 1-18.
2. Couldwell WT, de Tribolet N, Antel JP, Gauthier T and Kuppner MC, 1992, Adhesion molecules and malignant gliomas: implications for tumorigenesis. J Neurosurg, 76, 782-91.
3. Mignatti P and Rifkin DB, 1993, Biology and biochemistry of proteinases in tumor invasion. Physiol Rev, 73, 161-95.
4. Moscatelli D and Rifkin DB, 1988, Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta, 948, 67-85.
5. Vassalli J-D and Pepper MS, 1994, Membrane proteases in focus. Nature, 370, 14-15.
6. Cockett MI, Birch ML, Murphy G, Hart IR and Docherty AJ, 1994, Metalloproteinase domain structure, cellular invasion and metastasis. Biochem Soc Trans, 22, 55-7.
7. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370, 61-5.
8. Rucklidge GJ, Edvardsen K and Bock E, 1994, Cell-adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness. Biochem Soc Trans, 22, 63-8.
9. Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RCJ and Stack MS, 1994, Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer, 56, 552-9.
10. 1 integrins during human melanoma cell invasion. Cancer Res, 53, 3411-15.
11. Agarwal C, Hembree JR, Rorke EA and Eckert RL, 1994, Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res, 54, 943-9.
12. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD and Stetler-Stevenson WG, 1991, Tumor cell invasion inhibited by TIMP-2 [see comments]. J Natl Cancer Inst, 83, 775-9.
13. Davies B, Waxman J, Wasan H, et al. 1993, Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 53, 5365-9.
14. Lund-Johansen M, Rucklidge GJ, Milne G and Bjerkvig R, 1991, A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res, 11, 1001-6.
15. Vaithilingam IS, McDonald W, Brown NK, Stroude E, Cook RA and Del Maestro RF, 1992, Serum proteolytic activity during the growth of C6 astrocytoma. J Neurosurg, 77, 595-600.
16. Nakagawa T, Kubota T, Kabuto M et al, 1994, Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg, 00, 000-000.
17. Del Maestro RF, Lopez-Torres M, McDonald WB, et al. 1992, The effect of tumor necrosis factor-α on human malignant glial cells. J Neurosurg, 76, 652-9.
18. Paganetti PA, Caroni P and Schwab ME, 1988, Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol, 107, 2281-91.
19. Bjerkvig R, Laerum OD and Mella O, 1986, Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res, 46, 4071-9.
20. Apodaca G, Rutka JT, Bouhana K, et al. 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res, 50, 2322-9.
21. Abe T, Mori T, Kohno et al. 1994, Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis, 12, 296-304.
22. Couldwell WT, Antel JP, Apuzzo MLJ and Yong VW, 1990, Inhibition of growth of established human glioma lines by modulators of the protein kinase C second messenger system. 72, 349. (Abstract).
23. Couldwell WT, Antel JP, Apuzzo MLJ and Yong VW, 1990, Inhibition of growth of established human glioma lines by modulators of the protein kinase C system. J Neurosurg, 73, 594-600.
24. Couldwell WT, Uhm JH, Antel JP and Yong VW, 1991, Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery, 29, 880-7.
25. Couldwell WT, Antel JP and Yong VW, 1992, Protein kinase C (PKC) activity correlates with growth rate of gliomas. II: Effects of glioma mitogens and modulators of PKC. Neurosurgery, 31, 717-24.
26. Collins VP, 1983, Cultured human glial and glioma cells. Int Rev Exp Pathol, 24, 135-92.
27. Yong VW, Tejada-Berges T, Goodyer CG, Antel JP and Yong FP, 1992, Differential proliferative responses of human and mouse astrocytes to gamma-interferon. Glia, 6, 269-80.
28. Bruns RF, Miller FD, Merriman RL et al. 1991, Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun, 176, 288-93.
29. Albini A, Iwamoto Y, Kleinman HK et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3329-245.
30. Overall C, Wrana J and Sodek J, 1989, Independent regulation of collagenase, 72 kDa progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem, 264, 1860-9.
31. Mainardi C, Hasty K and Hibbs M, 1984, Antibody to rabbit macrophage type V collagenase/gelatinase and its use to further characterize the enzyme. Collagen Rel Res, 4, 209-17.
32. Baltuch GH, Couldwell WT, Villemure J-G and Yong VW, 1993, Protein kinase C inhibitors suppress cell growth in established and low passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery, 33, 495-501.
33. Ramos-DeSimone N and French DL, 1994, Monoclonal antibodies to human MMP-9. 732, 469-71 (Abstract).
34. Baxter DA, Johnston D and Strittmatter WJ, 1983, Protease inhibitors implicate metalloprotease in synaptic transmission at the mammalian neuromuscular junction. Proc Natl Acad Sci, 80, 4174-8.
35. Stoppelli MP, Verde P, Grimaldi G, Locatelli EK and Blasi F, 1986, Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate. J Cell Biol, 102, 1235-41.
36. Basu A, 1993, The potential of protein kinase C as a target for anticancer treatment. Pharmac Ther, 59, 257-80.
37. Schwartz GK, Redwood SM, Ohnuma T, Holland JF, Droller MJ and Liu BC-S, 1990, Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst, 82, 1753-56.
38. Matrisian LM, 1994, Matrix metalloproteinase gene expression. A NY Acad Sci, 732, 42-50.
39. r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res, 51, 439-44.
40. Liotta LA, Rao NC and Wewer UM, 1986, Biochemical interactions of tumor cells with the basement membrane. A Rev Biochem, 55, 1037-57.
41. Yamagata S, Tanaka R, Ito Y and Shimizu S, 1989, Gelatinases of murine metastatic tumor cells. Biochem Biophys Res Commun, 158, 228-34.
42. r 92,000 type IV collagenase in human brain tumors. Cancer Res, 53, 2208-11.
43. Rao JS, Steck PA, Tofilon et al. 1994, Role of plasminogen activator and of 92-kDa type IV collagenase in glioblastoma invasion using an in vitro Matrigel model. J Neurooncol, 18, 129-38.
44. Parisi JE and Scheithauer BW, 1993, Glial tumors. In: Nelson JS, Parisi JE and Schochet SS Jr eds. Principles and Practice of Neuropathology, St Louis: Mosby, pp. 123-84.
45. Herron GS, Banda MJ, Clark EJ, Gavrilovic J and Werb Z, 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem, 261, 2814-18.
46. Herron GS, Werb Z, Dwyer K and Banda MJ, 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem, 261, 2810-13.
47. Kapila S, Lee C and Richards DW, 1995, Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells. J Dent Res, 74, 1328-36.
48. Cook TF, Burke JS, Bergman KD, Quinn CO, Jeffrey JJ and Partridge NC, 1994, Cloning and regulation of rat tissue inhibitor of metalloproteinase-2 in oesteoblastic cells. Arch Biochem Biophys, 311, 313-20.
49. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI and Welgus HG, 1991, Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases. metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol, 146, 1286-93.
50. Fini ME and Girard MT, 1990, The pattern of metalloproteinase expression of corneal fibroblasts is altered by passage in cell culture. J Cell Sci, 97, 373-83.
51. Sottile J, Mann DM, Diemer V and Millis AJ, 1989, Regulation of collagenase and collagenase mRNA production in early- and late-passage human diploid fibroblasts. J Cell Physiol, 138, 281-90.
52. Lamph WW, Wamsley P, Sassone-Corsi P and Verma IM, 1988, Induction of proto-oncogene jun/AP-1 by scrum and TPA. Nature, 334, 629-31.
53. Greenberg ME and Ziff EB, 1984, Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature, 311, 433-8.
54. Mackay AR, Ballin M, Pelina MD, et al. 1992, Effect of phorbol ester and cytokines of matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metast, 12, 168-184.
55. Gopalakrishna R and Barsky SH, 1988, Tumor promoter-induced membrane-bound kinase C regulates hematogenous metastasis. Proc Natl Acad Sci, 85, 612-16.
56. Takenaga K and Takahashi K, 1986, Effects of 15-O-tetradecanylphorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Res, 40, 375-80.
57. 2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells. Cancer Res, 49, 2597-602.
58. Nabeshima K, Komada N, Kishi J, Koita H, Inoue T and Hayakawa T, 1993, TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but no metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. Int J Cancer, 55, 974-81.
59. Schwartz GK, Jiang J, Kelsen D and Albino AP, 1994, Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst, 85, 402-7.
60. Gross JL, Moscatelli D, Jaffe EA and Rifkin DB, 1982, Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol, 95, 974-81.
61. Overall CM, 1994, Regulation of tissue inhibitor of matrix metalloproteinase expression. In: Greenwald RA and Golub LM, eds. Inhibition of Matrix Metalloproteinases: therapeutic potential. New York: The New York Academy of Sciences, pp. 51-64.
62. Tanaka K, Iwamoto Y, Ito Y, et al. 1995, Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res, 55, 2927-35.
63. Rutka JT, Matsuzawa K, Hubbard SL, et al. 1995, Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Oncol, 6, 877-84.